ATE100797T1 - Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen. - Google Patents

Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.

Info

Publication number
ATE100797T1
ATE100797T1 AT90902343T AT90902343T ATE100797T1 AT E100797 T1 ATE100797 T1 AT E100797T1 AT 90902343 T AT90902343 T AT 90902343T AT 90902343 T AT90902343 T AT 90902343T AT E100797 T1 ATE100797 T1 AT E100797T1
Authority
AT
Austria
Prior art keywords
ring
phenyl
alkyl
atoms
optionally substituted
Prior art date
Application number
AT90902343T
Other languages
English (en)
Inventor
Keith Blakeney Mallion
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Application granted granted Critical
Publication of ATE100797T1 publication Critical patent/ATE100797T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
AT90902343T 1989-02-03 1990-02-01 Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen. ATE100797T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898902405A GB8902405D0 (en) 1989-02-03 1989-02-03 Heterocyclic compounds
EP90902343A EP0408714B1 (de) 1989-02-03 1990-02-01 Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
PCT/GB1990/000163 WO1990008762A1 (en) 1989-02-03 1990-02-01 Heterocyclic sulphonylnitrometanes, process for their preparation and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE100797T1 true ATE100797T1 (de) 1994-02-15

Family

ID=10651067

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902343T ATE100797T1 (de) 1989-02-03 1990-02-01 Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.

Country Status (15)

Country Link
US (1) US5096918A (de)
EP (1) EP0408714B1 (de)
JP (1) JPH03503900A (de)
AT (1) ATE100797T1 (de)
AU (1) AU631400B2 (de)
CA (1) CA2025664A1 (de)
DE (1) DE69006274D1 (de)
GB (1) GB8902405D0 (de)
GR (1) GR1000444B (de)
IE (1) IE900255L (de)
IL (1) IL93177A0 (de)
NZ (1) NZ232348A (de)
PT (1) PT93051A (de)
WO (1) WO1990008762A1 (de)
ZA (1) ZA90637B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250570A (en) * 1990-08-02 1993-10-05 Imperial Chemical Industries Plc Amidobenzene derivatives, compositions and use
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
WO1994007867A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
US5516534A (en) * 1993-11-26 1996-05-14 Rensselaer Polytechnic Institute Composition and method for reducing structural defects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1229653A (de) * 1968-03-14 1971-04-28
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
IE900255L (en) 1990-08-03
GB8902405D0 (en) 1989-03-22
EP0408714A1 (de) 1991-01-23
DE69006274D1 (de) 1994-03-10
AU631400B2 (en) 1992-11-26
NZ232348A (en) 1992-04-28
ZA90637B (en) 1990-10-31
PT93051A (pt) 1990-08-31
US5096918A (en) 1992-03-17
IL93177A0 (en) 1990-11-05
AU5020890A (en) 1990-08-24
GR900100067A (en) 1991-06-28
CA2025664A1 (en) 1990-08-04
WO1990008762A1 (en) 1990-08-09
GR1000444B (el) 1992-07-30
EP0408714B1 (de) 1994-01-26
JPH03503900A (ja) 1991-08-29

Similar Documents

Publication Publication Date Title
AU7991782A (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
DE122009000040I2 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
ATE100797T1 (de) Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
DE3061561D1 (en) Phenyl piperazine derivatives, their preparation and antiagressive medicines containing them
ES447646A1 (es) Procedimiento para la preparacion de nuevas tiazolinas.
DE3787844D1 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
ATE59647T1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ATE49971T1 (de) Imidazo(1,2-a>-pyrimidine und ihre salze mit saeuren, verfahren und zwischenprodukte zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zubereitungen.
DE3678645D1 (de) Neue thieno-1,2-thiazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE105837T1 (de) Arylsulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ATE15667T1 (de) Neue substituierte 3,5-diamino-1,2,4-oxadiazole und 3,5-diamino-1,2,4-thiadiazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JPS56133292A (en) Novel derivatives of cycloheptoindole, salts with their acids, their manufacture, application as drug and composition containing them
ATE2527T1 (de) Thienylbenzoesaeurederivate, verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen.
ATE29251T1 (de) Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE4541T1 (de) Alkyl- und cycloalkylsubstituierte 2-(2-(2hydroxy-3-tert.-butylamino-propoxy)-5-acylamino phenyl)-1,3,4-oxadiazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen.
SE8804696D0 (sv) Dioxazocine derivatives their preparation and compositions containing them
AU601942B2 (en) New esters derived from 4-hydroxy-3-quinoline carboxylic acid substituted by an alpha-hydroxyl chain at position 2, their preparation, their use as a medicament and the compositions containing them
MY102282A (en) Isoxazole derivatives with antiviral activities and pharmaceutical products containing these.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media